Heart disease may accompany extraglandular involvement ...

Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "Anti-Nuclear Antibody (ANA) Testing - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Antinuclear ...

Bruton’s tyrosine kinase inhibitors such as ibrutinib have significantly improved outcomes for chronic lymphocytic leukemia, ...

Johnson & Johnson's Imaavy has become the first FcRn blocker to be approved in the EU as a treatment for both adolescent and ...

Sjögren's disease, a heterogeneous autoimmune disorder characterized by exocrine glandular dysfunction, has a wide spectrum of manifestations. Clinical symptoms can be difficult to characterize, and ...

Diagnosis can take multiple tests, including some blood tests to detect antibodies that mistakenly latch onto healthy tissue. It usually centers on symptoms and involves ruling out other causes.

What are called autoimmune diseases can affect just about every part of the body — even the brain — and tens of millions of people. While most common in women, these diseases can strike anyone, adults ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

Detailed price information for Zai Lab Ltd ADR (ZLAB-Q) from The Globe and Mail including charting and trades.

Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.